Abstract:The aging of the central nervous system(CNS) is a primary contributor to neurodegenerative diseases in older individuals and significantly impacts their quality of life. Neuroinflammation, characterized by activation of microglia(MG) and release of cytokines, is closely associated with the onset of these neurodegenerative diseases. The activated status of MG is modulated by specifically programmed metabolic changes under various conditions. Succinylation, a novel post-translational modification(PTM) mainly involved in regulating mitochondrial energy metabolism pathways, remains unknown in its role in MG activation and aging. In the present study, we found that succinylation levels were significantly increased both during aging and upon lipopolysaccharide-induced(LPS-induced) MG activation undergoing metabolic reprogramming. Up-regulated succinylation induced by sirtuin 5 knockdown(Sirt5 KD) in microglial cell line BV2 resulted in significant up-regulation of aging-related genes, accompanied by impaired mitochondrial adaptability and a shift towards glycolysis as a major metabolic pathway. Furthermore, after LPS treatment, Sirt5 KD BV2 cells exhibited increased generation of reactive oxygen species(ROS), accumulation of lipid droplets, and elevated levels of lipid peroxidation. By employing immunoprecipitation, introducing point mutation to critical succinylation sites, and conducting enzyme activity assays for succinate dehydrogenase(SDH) and trifunctional enzyme subunit alpha(ECHA), we demonstrated that succinylation plays a regulatory role in modulating the activities of these mitochondrial enzymes. Finally, down-regulation the succinylation levels achieved through administration of succinyl phosphonate(SP) led to amelioration of MG senescence in vitro and neuroinflammation in vivo. To our knowledge, our data provide preliminary evidence indicating that up-regulated succinylation modifications elicit a senescence phenotype in MG through alterations in energy metabolism. Moreover, these findings suggest that manipulation of succinylation levels may offer valuable insights into the treatment of aging-related neuroinflammation.

Role of succinylation modification in central nervous system diseases

Succinylation Links Metabolism to Protein Functions

Dysregulation of protein succinylation and disease development

Succinylation and redox status in cancer cells

Up-regulated succinylation modifications induce a senescence phenotype in microglia by altering mitochondrial energy metabolism

A review of the mechanism of succinylation in cancer

Post-translational modifications in mitochondria: protein signaling in the powerhouse

The Role of Protein S-Nitrosylation in Mitochondrial Quality Control in Central Nervous System Diseases

The Mystery of Extramitochondrial Proteins Lysine Succinylation

The Critical Roles of the SUMO-Specific Protease SENP3 in Human Diseases and Clinical Implications

Genetic, epigenetic and biochemical regulation of succinate dehydrogenase function

Alpha‐ketoglutarate Dehydrogenase Complex‐dependent Succinylation of Proteins in Neurons and Neuronal Cell Lines

Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies

Unraveling the protein post-translational modification landscape: Neuroinflammation and neuronal death after stroke

Control of Mitochondria-Associated Endoplasmic Reticulum Membranes by Protein S-palmitoylation: Novel Therapeutic Targets for Neurodegenerative Diseases.

Succinate metabolism: a promising therapeutic target for inflammation, ischemia/reperfusion injury and cancer

S-Glutathionylation and S-Nitrosylation in Mitochondria: Focus on Homeostasis and Neurodegenerative Diseases

Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in Neurodegeneration

Mitochondrial SENP2 Regulates the Assembly of SDH Complex under Metabolic Stress

Post-translational modification and mitochondrial function in Parkinson's disease

Impact of Lysine Succinylation on the Biology of Fungi